Trial Profile
Immunogenicity and Safety of a Booster Dose of GlaxoSmithKline Biologicals' IPV (PoliorixTM) in Healthy Chinese Toddlers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2023
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine inactivated (Primary) ; Hib-DTaP vaccine
- Indications Poliomyelitis
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline; GSK
- 04 Oct 2016 New trial record